NASDAQ:CLRB

Cellectar Biosciences Stock Insider Trading

etoro logo Buy CLRB
*Your capital is at risk
$2.74
-0.230 (-7.74%)
At Close: Jun 02, 2026

Cellectar Biosciences Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be positive at 99.84. In total, the insiders bought 12.7M and sold 198 CLRB shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power

(Last 100 transactions)
99.84
Buy 12.7M shares
Sell 198 shares
99% Buy Activity
Negligible or No Correlation
Buy Signal High Confidence
May 07, 2026

Analysis Breakdown:

  • Strongly supported by a very high Insider Power Score of 99.84.
  • Confidence increased due to high data reliability score of 100.
  • Supported by overwhelming buy-side pressure (99% buys).

Historical Insider Trades

Date Type Person Role Amount
Jun 23, 2023
Buy
Stock option (right to buy)
A-Award
Lea Darrell Shane
Chief Commercial Officer
Officer 100 000
Value: $168.0K
Jun 23, 2023
Buy
Stock option (right to buy)
A-Award
Kolean Chad J
Chief Financial Officer
C-Suite Officer 104 000
Value: $174.7K
Jun 23, 2023
Buy
Stock option (right to buy)
A-Award
Longcor Jarrod
Chief Operating Officer
C-Suite Officer 144 000
Value: $241.9K
Jun 23, 2023
Buy
Stock option (right to buy)
A-Award
Caruso James V
President And CEO
CEO / President 261 000
Value: $438.5K
Jun 23, 2023
Buy
Stock option (right to buy)
A-Award
Caruso James V
President And CEO
CEO / President 261 000
Value: $438.5K
Jun 23, 2023
Buy
Stock option (right to buy)
A-Award
Longcor Jarrod
Chief Operating Officer
C-Suite Officer 144 000
Value: $241.9K
Jun 23, 2023
Buy
Stock option (right to buy)
A-Award
Kolean Chad J
Chief Financial Officer
C-Suite Officer 104 000
Value: $174.7K
Jun 23, 2023
Buy
Stock option (right to buy)
A-Award
Lea Darrell Shane
Chief Commercial Officer
Officer 100 000
Value: $168.0K
Feb 15, 2023
Buy
Stock option (right to buy)
A-Award
Shustov Andrei
Senior Vice President, Medical
CEO / President 100 000
Value: $167.0K
Feb 15, 2023
Buy
Common Stock
Shustov Andrei
Senior Vice President, Medical
CEO / President 0
Value: $0
Feb 15, 2023
Buy
Common Stock
Shustov Andrei
Senior Vice President, Medical
CEO / President 0
Value: $0
Feb 15, 2023
Buy
Stock option (right to buy)
A-Award
Shustov Andrei
Senior Vice President, Medical
CEO / President 100 000
Value: $167.0K
Jan 17, 2023
Buy
Stock option (right to buy)
A-Award
Longcor Jarrod
Chief Operating Officer
C-Suite Officer 144 000
Value: $0
Jan 17, 2023
Buy
Stock option (right to buy)
A-Award
Caruso James V
President And CEO
CEO / President 261 000
Value: $0
Jan 17, 2023
Buy
Stock option (right to buy)
A-Award
Kolean Chad J
Chief Financial Officer
C-Suite Officer 104 000
Value: $0
Jan 17, 2023
Buy
Stock option (right to buy)
A-Award
Kolean Chad J
Chief Financial Officer
C-Suite Officer 104 000
Value: $0
Jan 17, 2023
Buy
Stock option (right to buy)
A-Award
Caruso James V
President And CEO
CEO / President 261 000
Value: $0
Jan 17, 2023
Buy
Stock option (right to buy)
A-Award
Longcor Jarrod
Chief Operating Officer
C-Suite Officer 144 000
Value: $0
Nov 21, 2022
Buy
Stock option (right to buy)
A-Award
Lea Darrell Shane
Chief Commercial Officer
Officer 100 000
Value: $0
Nov 21, 2022
Buy
Common Stock
J-Other
Lea Darrell Shane
Insider
Unknown 0
Value: $0
Nov 21, 2022
Buy
Common Stock
J-Other
Lea Darrell Shane
Insider
Other 0
Value: $0
Nov 21, 2022
Buy
Common Stock
J-Other
Lea Darrell Shane
Insider
Other 0
Value: $0
Nov 21, 2022
Buy
Common Stock
J-Other
Lea Darrell Shane
Insider
Unknown 0
Value: $0
Nov 21, 2022
Buy
Stock option (right to buy)
A-Award
Lea Darrell Shane
Chief Commercial Officer
Officer 100 000
Value: $0
Jun 24, 2022
Buy
Stock option (right to buy)
A-Award
Swirsky Douglas J
Director 11 700
Value: $0

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

Click to get the best stock tips daily for free!
ABOUT CELLECTAR BIOSCIENCES
Cellectar Biosciences
Cellectar Biosciences, Inc., a clinical biopharmaceutical company, focuses on the discovery, development, and commercialization of drugs for the treatment of cancer. Its lead phospholipid drug conjugate (PDC) candidate is CLR 131 (iopofosine I-131), which is in Phase 2 clinical study in patients with relapsed or refractory (r/r) Waldenstrom's macroglobulinemia and B-cell malignancies; Phase 2B clinical study in r/r multiple myeloma (MM) patients;...
GOLDEN STAR
Ticker Change Signal Date
RUN
$12.83
18.86% May 06
GLBE
$31.61
5.35% May 05
SAP
$172.39
10.69% May 05
W
WCLD
$27.34
27.18% Apr 29
ADBE
$243.57
7.61% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE